These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 27410239

  • 21. Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016.
    Moro PL, Zheteyeva Y, Barash F, Lewis P, Cano M.
    Vaccine; 2018 Jan 02; 36(1):50-54. PubMed ID: 29174107
    [Abstract] [Full Text] [Related]

  • 22. The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barré syndrome.
    Miller ER, McNeil MM, Moro PL, Duffy J, Su JR.
    Vaccine; 2020 Nov 03; 38(47):7458-7463. PubMed ID: 33039207
    [Abstract] [Full Text] [Related]

  • 23. Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021.
    Moro PL, Olson CK, Clark E, Marquez P, Strid P, Ellington S, Zhang B, Mba-Jonas A, Alimchandani M, Cragan J, Moore C.
    Vaccine; 2022 May 26; 40(24):3389-3394. PubMed ID: 35489985
    [Abstract] [Full Text] [Related]

  • 24. Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015-2018.
    Perez-Vilar S, Dores GM, Marquez PL, Ng CS, Cano MV, Rastogi A, Lee L, Su JR, Duffy J.
    Vaccine; 2022 Jan 21; 40(2):247-254. PubMed ID: 34887130
    [Abstract] [Full Text] [Related]

  • 25. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).
    Shimabukuro TT, Nguyen M, Martin D, DeStefano F.
    Vaccine; 2015 Aug 26; 33(36):4398-405. PubMed ID: 26209838
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021-June 30, 2022.
    Moro PL, Zhang B, Ennulat C, Harris M, McVey R, Woody G, Marquez P, McNeil MM, Su JR.
    Vaccine; 2023 Mar 10; 41(11):1859-1863. PubMed ID: 36669964
    [Abstract] [Full Text] [Related]

  • 30. Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.
    Woo EJ, Moro PL, Cano M, Jankosky C.
    Vaccine; 2017 Oct 09; 35(42):5618-5621. PubMed ID: 28886946
    [Abstract] [Full Text] [Related]

  • 31. Safety Surveillance of Varicella Vaccines in the Vaccine Adverse Event Reporting System, United States, 2006-2020.
    Moro PL, Leung J, Marquez P, Kim Y, Wei S, Su JR, Marin M.
    J Infect Dis; 2022 Oct 21; 226(Suppl 4):S431-S440. PubMed ID: 36265846
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
    Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, West DJ, Anthrax Vaccine Export Committee.
    Pharmacoepidemiol Drug Saf; 2002 Oct 21; 11(3):189-202. PubMed ID: 12051118
    [Abstract] [Full Text] [Related]

  • 36. Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012.
    Rabe IB, Miller ER, Fischer M, Hills SL.
    Vaccine; 2015 Jan 29; 33(5):708-12. PubMed ID: 25498208
    [Abstract] [Full Text] [Related]

  • 37. Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007-2017.
    Moro PL, Arana J, Marquez PL, Ng C, Barash F, Hibbs BF, Cano M.
    Vaccine; 2019 Jun 19; 37(28):3730-3734. PubMed ID: 31155414
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
    Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, Ward BJ, West DJ.
    Pharmacoepidemiol Drug Saf; 2004 Dec 19; 13(12):825-40. PubMed ID: 15386719
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.